Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:904682.
doi: 10.1155/2009/904682. Epub 2009 Jul 12.

Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction

Katarina Kollar  1 , Matthew M Cook, Kerry Atkinson, Gary Brooke
Affiliations

Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction

Katarina Kollar et al. Int J Cell Biol. 2009.

Abstract

Mesenchymal stem cells or multipotent mesenchymal stromal cells (both referred to as MSC) have been shown in some studies to have a beneficial effect on myocardial recovery after infarct. Current strategies for MSC delivery to heart involve intravenous, intraarterial, and intramuscular delivery. Different routes of MSC delivery and a lack of knowledge of the mechanisms that MSC utilise to migrate in vivo has most likely led to the marked variations in results that have been found. This review aims to summarise the current knowledge of MSC migratory mechanisms and looks to future methods of MSC manipulation prior to delivery in order to enhance MSC migration and engraftment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of the molecular mechanisms used by (a) leukocytes for homing to the bone marrow and (b) differences with MSC.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bonow RO, Smaha LA, Smith SC, Jr., Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 2002;106(13):1602–1605. - PubMed
    1. Barlow S, Brooke G, Chatterjee K, et al. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells and Development. 2008;17(6):1095–1107. - PubMed
    1. Brooke G, Rossetti T, Pelekanos R, et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. British Journal of Haematology. 2009;144(4):571–579. - PubMed
    1. Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells. 2006;24(11):2582–2591. - PubMed
    1. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301–313. - PubMed

LinkOut - more resources